Wednesday, May 15, 2019
Medical News Today: Novel Alzheimer's drug passes first phase of human testing
A drug that tackles toxic protein buildup in Alzheimer's disease in a novel way has passed phase 1 of clinical trials, which tests safety in humans.
Related Posts:
39% in Kentucky had symptoms of an anxiety or depressive disorder Feb. 3-15; community mental health centers can help them
CDC issues guidance for fully vaccinated people
Guidance for vaccinated is yellow light, not green one, officials say, warning that we're still in race with more contagious strains
Positive-test rate rises; state has more new cases than last Sun.
With just six days left in Kentucky's short legislative session, many health-related bills are near final passage; here's a roundup
0 comments:
Post a Comment